Rifampin
Rifadin, Rimactane (rifampin) is a small molecule pharmaceutical. Rifampin was first approved as Rifadin on 1982-01-01. It is used to treat aids-related opportunistic infections, bacterial infections, bacterial meningitis, brucellosis, and haemophilus infections amongst others in the USA. It is known to target solute carrier organic anion transporter family member 1A2, solute carrier organic anion transporter family member 1B1, solute carrier organic anion transporter family member 1B3, and nuclear receptor subfamily 1 group I member 2.
| Trade Name | Rifadin, Rimactane |
|---|---|
| Common Name | Rifampin |
| Indication | aids-related opportunistic infections, bacterial infections, bacterial meningitis, brucellosis, haemophilus infections, legionnaires' disease, leprosy, staphylococcal infections, tuberculosis |
| Drug Class | Tricyclic compounds; antibiotics (rifamycin derivatives) |
